Source: MBCV report 2018
Multiple myeloma is the third most common form of blood cancer in Japan,24 with 8,200 cases projected in 2017, and more than 4,000 deaths in the same year. 25
In 2013, there were 11,968 cases of leukemia in Japan. 23
Although Japan’s five-year survival rate is at 62.1%,26 the five-year survival rate for patients with blood cancers like leukemia in adults (33.3%) is lower than the United States (46.7%) and Australia (51.8%) . 27
Other five-year survival rate for patients in Japan:
Lymphoma
65.5% 27
Multiple myeloma (MM)
36.4% 27
The mortality rate of MM in Japan was 3.5% in 2016. 28
In 2017, a pharmaceutic company undertook a study in Japan asking 2,000 members of the general population about blood cancer. The study revealed the need for more work in making blood cancer visible. The results are featured in the pages that follow. 9
(source: MBCV Report 2018. Image is adopted from MBCV with modification)
